Blockade of macrophage colony-stimulating factor reduces macrophage proliferation and accumulation in renal allograft rejection

American Journal of Transplantation

Volumn 3, Issue 3, 2003, Pages 294-300

  Jose, Matthew D ^a   Le Meur, Yannick ^a   Atkins, Robert C ^a   Chadban, Steven J ^a  

^a MONASH MEDICAL CENTRE   (Australia)

Author keywords

Acute rejection; c fms; Kidney; M CSF; Macrophage proliferation

Indexed keywords

ANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; COLONY STIMULATING FACTOR 1; COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 2 RECEPTOR;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; GLOMERULUS; ISOGRAFT; KIDNEY ALLOGRAFT REJECTION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; T LYMPHOCYTE; TREATMENT OUTCOME;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD8; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELL DIVISION; GRAFT REJECTION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY GLOMERULUS; KIDNEY TRANSPLANTATION; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; RECEPTORS, INTERLEUKIN-2; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0037355619     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2003.00068.x     Document Type: Article

References (43)

1. Hancock WW, Thomson NM, Atkins RC. Composition of interstitial cellular infiltrate identified by monoclonal antibodies in renal biopsies of rejecting human renal allografts. Transplantation 1983; 35: 458-463.
2. Grimm PC, McKenna R, Nickerson P et al. Clinical rejection is distinguished from subclinical rejection by increased infiltration by a population of activated macrophages. J Am Soc Nephrol 1999; 10: 1582-1589.
3. Hall BM. Cells mediating allograft rejection. Transplantation 1991; 51: 1141-1151.
4. Auchincloss H Jr, Lee R, Shea S, Markowitz JS, Grusby MJ, Glimcher LH. The role of 'indirect' recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc Natl Acad Sci USA 1993; 90: 3373-3377.
5. + cells are essential for allorejection. J Exp Med 1996; 184: 2013-2018.
6. Grandaliano G, Gesualdo L, Ranieri E, Monno R, Stallone G, Schena FP. Monocyte chemotactic peptide-1 expression and monocyte infiltration in acute renal transplant rejection. Transplantation 1997; 63: 414-420.
7. Pattison J, Nelson PJ, Huie P et al. RANTES chemokine expression in cell-mediated transplant rejection of the kidney. Lancet 1994; 343: 209-211.
8. Grau V, Gemsa D, Steiniger B, Garn H. Chemokine expression during acute rejection of rat kidneys. Scand J Immunol 2000; 51: 435-440.
9. Lan HY, Yang N, Brown FG et al. Macrophage migration inhibitory factor expression in human renal allograft rejection. Transplantation 1998; 66: 1465-1471.
10. Le Meur Y, Jose MD, Mu W, Atkins RC, Chadban SJ. Macrophage colony-stimulating factor expression and macrophage accumulation in renal allograft rejection. Transplantation 2002; 73: 1318-1324.
11. Kerr PG, Nikolic-Paterson DJ, Lan HY, Tesch G, Rainoe S, Atkins RC. Deoxyspergualin suppresses local macrophage proliferation in rat renal allograft rejection. Transplantation 1994; 58: 596-601.
12. Grau V, Herbst B, Steiniger B. Dynamics of monocytes/macrophages and T lymphocytes in acutely rejecting rat renal allografts. Cell Tissue Res 1998; 291: 117-126.
13. Tushinski RJ, Oliver IT, Guilbert LJ, Tynan PW, Warner JR, Stanley ER. Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy. Cell 1982; 28: 71-81.
14. Tushinski RJ, Stanley ER. The regulation of mononuclear phagocyte entry into S phase by the colony stimulating factor CSF-1. J Cell Physiol 1985; 122: 221-228.
15. Sherr CJ, Rettenmier CW, Sacca R, Roussel MF, Look AT, Stanley ER. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 1985; 41: 665-676.
16. Sudo T, Nishikawa S, Ogawa M et al. Functional hierarchy of c-kit and c-fms in intramarrow production of CFU-M. Oncogene 1995; 11: 2469-2476.
17. Skoskiewicz M, Chase C, Winn HJ, Russell PS. Kidney transplants between mice of graded immunogenetic diversity. Transplant Proc 1973; 5: 721-725.
18. Han WR, Murray-Segal LJ, Mottram PL. Modified technique for kidney transplantation in mice. Microsurgery 1999; 19: 272-274.
19. Zhang Z, Zhu L, Quan D et al. Pattern of liver, kidney, heart, and intestine allograft rejection in different mouse strain combinations. Transplantation 1996; 62: 1267-1272.
20. Murayama T, Yokode M, Kataoka H et al. Intraperitoneal administration of anti-c-fms monoclonal antibody prevents initial events of atherogenesis but does not reduce the size of advanced lesions in apolipoprotein E-deficient mice. Circulation 1999; 99: 1740-1746.
21. Isbel NM, Hill PA, Foti R et al. Tubules are the major site of M-CSF production in experimental kidney disease: correlation with local macrophage proliferation. Kidney Int 2001; 60: 614-625.
22. Mitchell R, Bacher M, Bernhagen J, Pushkarskaya T, Seldin MF, Bucala R. Cloning and characterization of the gene for mouse macrophage migration inhibitory factor (MIF). J Immunol 1995; 154: 3863-3870.
23. Yoshimura T, Takeya M, Takahashi K. Molecular cloning of rat monocyte chemoattractant protein-1 (MCP-1) and its expression in rat spleen cells and tumor cell lines. Biochem Biophys Res Commun 1991; 174: 504-509.
24. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723.
25. Grone HJ, Weber C, Weber KS et al. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment. FASEB J 1999; 13: 1371-1383.
26. Lan HY, Mu W, Nikolic-Paterson DJ, Atkins RC. A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody cross-reactivity and retrieve antigens. J Histochem Cytochem 1995; 43: 97-102.
27. Tesch GH, Hill PA, Wei M, Nikolic-Paterson DJ, Dutartre P, Atkins RC. LF15-0195 prevents the induction and inhibits the progression of rat anti-GBM disease. Kidney Int 2001; 60: 1354-1365.
28. Brown FG, Nikolic-Paterson DJ, Metz C, Bucala R, Atkins RC, Lan HY. Up-regulation of macrophage migration inhibitory factor in acute renal allograft rejection in the rat. Clin Exp Immunol 1999; 118: 329-336.
29. Isbel NM, Nikolic-Paterson DJ, Hill PA, Dowling J, Atkins RC. Local macrophage proliferation correlates with increased renal M-CSF expression in human glomerulonephritis. Nephrol Dial Transplant 2001; 16: 1638-1647.
30. Lan HY, Nikolic-Paterson DJ, Mu W, Atkins RC. Local macrophage proliferation in the progression of glomerular and tubulointerstitial injury in rat anti-GBM glomerulonephritis. Kidney Int 1995; 48: 753-760.
31. Philip R, Epstein LB. Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1. Nature 1986; 323: 86-89.
32. Vandenbroecke C, Caillat-Zucman S, Legendre C et al. Differential in situ expression of cytokines in renal allograft rejection. Transplantation 1991; 51: 602-609.
33. Morel D, Normand E, Lemoine C et al. Tumor necrosis factor alpha in human kidney transplant rejection - analysis by in situ hybridization. Transplantation 1993; 55: 773-777.
34. Nikolic-Paterson DJ, Lan HY, Atkins RC. Macrophages in immune renal injury. In: Neilson EG, Couser WG, eds. Immunologic Renal Disease. New York: Raven Press; 2001: p. 575.
35. Bingisser RM, Tilbrook PA, Holt PG, Kees UR. Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway. J Immunol 1998; 160: 5729-5734.
36. Mufson RA, Aghajanian J, Wong G, Woodhouse C, Morgan AC. Macrophage colony-stimulating factor enhances monocyte and macrophage antibody-dependent cell-mediated cytotoxicity. Cell Immunol 1989; 119: 182-192.
37. Penfield JG, Wang Y, Li S et al. Transplant surgery injury recruits recipient MHC class II-positive leukocytes into the kidney. Kidney Int 1999; 56: 1759-1769.
38. Ozdemir BH, Ozdemir FN, Gungen Y, Haberal M. Role of macrophages and lymphocytes in the induction of neovascularization in renal allograft rejection. Am J Kidney Dis 2002; 39: 347-353.
39. Song E, Zou H, Yao Y et al. Early application of Met-RANTES ameliorates chronic allograft nephropathy. Kidney Int 2002; 61: 676-685.
40. Gao W, Topham PS, King JA et al. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection. J Clin Invest 2000; 105: 35-44.
41. Gao W, Faia KL, Csizmadia V et al. Beneficial effects of targeting CCR5 in allograft recipients. Transplantation 2001; 72: 1199-1205.
42. Horuk R, Clayberger C, Krensky AM et al. A non-peptide functional antagonist of the CCR1 chemokine receptor is effective in rat heart transplant rejection. J Biol Chem 2001; 276: 4199-4204.
43. Hou G, Valujskikh A, Bayer J, Stavitsky AB, Metz C, Heeger PS. In vivo blockade of macrophage migration inhibitory factor prevents skin graft destruction after indirect allorecognition. Transplantation 2001; 72: 1890-1897.